NIAMS offers the Research Innovation for Scientific Knowledge (RISK) Grant for Skin and Rheumatic Diseases to support innovative research in non-traditional areas within the NIAMS mission. This grant encourages unconventional hypotheses and groundbreaking concepts related to skin and rheumatic diseases. It aims to fund translational studies focused on understanding disease mechanisms and developing diagnostics or therapeutics, excluding first in human studies. The RISK grant is ideal for projects deemed too risky or controversial for other NIH mechanisms. Applications for the R61/R33 initiative are welcomed until January 9, 2020.
Opportunity ID: 307504
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AR-19-012 |
| Funding Opportunity Title: | Research Innovations for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (R61/R33 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.846 — Arthritis, Musculoskeletal and Skin Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jul 23, 2018 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jan 09, 2020 |
| Current Closing Date for Applications: | Jan 09, 2020 |
| Archive Date: | Feb 14, 2020 |
| Estimated Total Program Funding: | $2,000,000 |
| Award Ceiling: | $250,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses Special district governments Private institutions of higher education Public housing authorities/Indian housing authorities County governments Independent school districts Small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments State governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The NIAMS Research Innovation for Scientific Knowledge (RISK) for Skin and Rheumatic Diseases (R61/R33) initiative focuses on innovative research within the NIAMS mission by encouraging applicants to pursue unusual observations, test imaginative hypotheses, investigate creative concepts, and build ground-breaking paradigms, all of which deviate significantly from the current prevailing theories or practice. This FOA is particularly designed to encourage the submission of projects that are considered too risky, premature, controversial, or unconventional for other NIH mechanisms. This FOA intends to support disease-focused translational studies. We invite research studies aimed at understanding the mechanisms of diseases or conditions relevant to the NIAMS mission, as well as studies aimed at developing or testing diagnostics, therapeutic agents, or preventive interventions up to, but not including, first in human studies. The RISK R61/R33 FOAs are not intended to support clinical trials. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AR-19-012.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | FORMS-E | PKG00243983 | Mar 09, 2019 | Jan 09, 2020 | View |
Package 1
Mandatory forms
307504 RR_SF424_2_0-2.0.pdf
307504 PHS398_CoverPageSupplement_4_0-4.0.pdf
307504 RR_OtherProjectInfo_1_4-1.4.pdf
307504 PerformanceSite_2_0-2.0.pdf
307504 RR_KeyPersonExpanded_2_0-2.0.pdf
307504 RR_Budget_1_4-1.4.pdf
307504 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
307504 RR_SubawardBudget30_1_4-1.4.pdf
307504 PHS_AssignmentRequestForm_2_0-2.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
